Company Announcements Horizon Discovery exclusively licensed in August new X-MAN (gene X-Mutant And Normal) cell lines from the University of Minnesota. Baseclick announced in August that it raised an additional €1.2 million ($1.7 million) from private investors and BASF Venture Capital in a second financing round. In September, ABR-Affinity BioReagents, a Thermo Fisher Scientific company, […]
Company Announcements In August, Pressure Biosciences received a notice from the NASDAQ Stock Market that it was not in compliance with the minimum bid price requirement for continued listing and has until February 2012 to regain compliance. In September, Sage Science closed a $2.0 million equity-financing round, according to an SEC filing. Sage Science announced […]
Company Announcements Mettler-Toledo acquired UK-based Triton Technology and its dynamic mechanical analyzer product line in March. In connection with the purchase, Lacerta Technology acquired Triton’s identiPol QA product line. Canadian-based Norton Scientific listed its stock on the Frankfurt Stock Exchange’s First Quotation Board (Open Market) in June. Norton Scientific named Shoko America its US West […]
The recent Chinese patent surge is being led by domestic patent applications, those which originated in China. The number of total patent applications filed in China grew 16.7% annually from 2006 to 2010, nearly doubling to 314,000. In 2010, 73% of China’s patent applications were domestic, compared with 52% in 2006. The global share of […]
R&D spending by the 1,400 firms in the 2011 “EU Industrial R&D Investment Scoreboard” increased 4.0% to €455.97 billion ($600.0 billion) in fiscal 2010, compared with a 1.9% decline in fiscal 2009. Fiscal 2010 sales for the firms grew 9.4%, after declining 10.1% the year before. The Scoreboard consists of 400 EU firms and 1,000 […]
Turkey’s gross domestic R&D expenditure (GERD) as a percentage of GDP was 8.4% in 2010, down slightly from 8.5% in 2009. In total, GERD by the business sector, public sector and universities grew 14.6% to TRY 9,268 million ($6.17 billion). In 2010, 46% of R&D was performed by the higher education sector, 43% was performed […]
Among the issues raised in a November report by the US Department of Energy’s (DOE) Office of Inspector General reviewing management challenges for fiscal 2012 was the cost of DOE labs. The report recommends the creation of an independent commission to analyze the DOE’s R&D lab complex. The DOE spends $10.4 billion annually to run […]
The World Steel Association’s October 2011 short-range outlook predicts that worldwide apparent steel use, which it defines as steel deliveries from domestic producers and importers and not from inventories, will increase 6.5% to 1,398 million metric tons (mmt) in 2011, down from 15.1% growth last year. Global steel demand should grow 5.4% in 2012. China […]
From 2010 to 2011, 10 of the 12 drug firms that spend the most on R&D had declining Internal Rates of Return (IRR), which is the return firms expect on investment. The firms were Pfizer, Sanofi, Takeda, Roche, AstraZeneca, Merck, Novartis, GlaxoSmithKline, Amgen, Eli Lilly, Johnson & Johnson and Bristol-Myers Squibb. The collective IRR for […]
For most of November, global equity prices slumped due to heightened apprehensions over European sovereign debt and unsustainable Treasury bond yields for those debt-ridden countries. In the US, positive economic data for the consumer sector and manufacturing was overshadowed by Europe and uncertainty surrounding the Congressional budget reduction. However, amid the anguish, the Federal Reserve […]
Pay Invoice
Latest Blogs
-
Perseverance Forecasted for the Pharmaceutical Market for Analytical and Scientific Instrumentation
October 24, 2024 5:17 pm
-
M&A Activity in the Analytical Instrumentation and Lab Tools Market. 2021-2023
September 30, 2024 1:32 pm
-
Survey Results: Life Science Labs and Sustainable Consumables
August 30, 2024 7:43 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
